2022 dividend forecasts: GSK, Barclays, Shell

What can income investors expect from these FTSE 100 shares in 2022? Roland Head takes a look at the latest dividend forecasts.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

I’m looking at 2022 dividend forecasts for three of the biggest income stocks in the FTSE 100. You might expect shareholder payouts from Royal Dutch Shell (LSE: RDSB), Barclays (LSE: BARC) and GlaxoSmithKline (LSE: GSK) to be boringly reliable. Sadly, that hasn’t been true in recent years.

Two of them cut their payouts last year. The third is planning a 2022 cut. So which would I buy today?

Shell looks bulletproof – for now

Shell sent shockwaves around the City last April when CEO Ben van Beurden cut the dividend by 65%. I think it was the right decision. The old payout just wasn’t affordable.

The good news is that Shell’s new dividend looks pretty safe to me. It’s also growing steadily and, after oil prices bounced back this year, van Beurden lifted Shell’s dividend by 38% at the half-year mark.

This was a one-off increase and Shell has told shareholders to expect a 4% increase each year. However, City analysts reckon the firm will do better than this. They’re forecasting a 10% dividend increase for 2022. If they’re right — and I think they could be — that would give Shell a 2022 forecast yield of 4.1% at current levels.

It’s too soon to know whether this fossil fuel producer can reinvent itself as a low-carbon energy business. It’s a tough task. But I’m comfortable with Shell today and would be happy to buy the shares for income in 2022.

GlaxoSmithKline: changes ahead

Pharmaceutical group GlaxoSmithKline hasn’t cut its dividend since 2005. But that’s about to change. When GSK separates its consumer healthcare business into a standalone unit next year, the combined dividend from the two companies is expected to fall by 31%, from 80p to around 55p.

From 2023, there’s no dividend guidance for the consumer business, which will be run separately. But the ‘New GSK’ dividend is expected to be set at 45p. This will mark the start of a new policy targeting a 40-60% payout ratio from earnings each year.

These numbers mean that Glaxo’s dividend yield is expected to fall to 3.5% in 2022 (including consumer healthcare) and 2.9% in 2023 (excluding consumer healthcare).

I’m cautiously optimistic that Glaxo’s performance should continue to improve. But I’m wary about buying the stock ahead of such a big restructuring that could still fail. For now, I’m keeping a watching brief.

Barclays gets new CEO – is the dividend safe?

Barclays’ former CEO Jes Staley exited the company under a cloud this week. New boss CS Venkatakrishnan (known as Venkat) has told staff that the bank’s existing strategy “is the right one”. But I think it’s fair to say that, over time, he’ll make some different decisions to his predecessor.

It’s too soon to know how these might affect Barclays’ dividend payouts and a leadership change is always a risk. But the bank’s recent third-quarter results suggest to me that the payout is likely to continue its recovery from last year’s cut.

Pre-tax profit for the quarter trebled to £6.9bn. Regulatory measures of surplus capital also improved. This suggests to me that the bank should be able to continue growing its dividend.

Broker forecasts suggest Barclays’ dividend will rise to 6p this year, just below the pre-pandemic level of 6.5p. In 2022, the bank’s expected to reward shareholders with a 28% dividend hike, lifting the payout to 7.7p. That’s equivalent to a forecast yield of 3.8%.

I’d consider buying Barclays at current levels.


Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head has no position in any of the shares mentioned. The Motley Fool UK has recommended Barclays and GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Low P/E ratios, yields up to 9%! Are these the FTSE 250’s best value stocks?

These FTSE 250 shares offer exceptional all-round value on paper. But are they too good to be true for investors…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Here’s how a 39-year-old could aim for a million by retirement, by spending £900 a month on UK shares

Our writer digs into the theory and practicalities of buying high-quality UK shares regularly to aim to retire as a…

Read more »

Businessman with tablet, waiting at the train station platform
Investing Articles

See how much a 50-year-old should invest to get a £1k monthly passive income at 65

Even at 50, there's still time to build a big enough stocks portfolio to generate a serious passive income at…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

With P/E ratios below 7, are these undervalued FTSE shares bargains — or value traps?

Low valuations aren’t always the bargains they seem. Mark Hartley takes a closer look at two FTSE shares trading at…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

3 simple strategies that can help drive success in the stock market on a small budget

Christopher Ruane runs through a trio of strategic moves he reckons can help an investor as they aim to build…

Read more »

British union jack flag and Parliament house at city of Westminster in the background
Investing Articles

2 growth stocks backed by this British fund that’s soared 77.8% in just 3 years!

Our writer likes the look of this under-the-radar fund, especially with a pair of exciting growth stocks near the top…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

Is there value in Baltic Classifieds — a soaring growth stock that brokers are buying?

Baltic Classifieds has surged after broker upgrades. Mark Hartley asks whether this FTSE 250 stock is really worth buying now.

Read more »

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£20k in an ISA? Here’s how it could be used to target £423 of passive income each month

Earning money from dividends in an ISA is one way to set up passive income streams. Our writer explains how…

Read more »